ARCHIVES

Final stats On FY92 Budget; Success Rate Was 35 Percent

This article is from The Cancer Letter archive.

Vol. 18 No. 47 | December 4, 1992

Download PDF Visit The Full Archive

Related Articles

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

Funding Opportunities

October 18, 2002